Eventide Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $9.93M | Sell |
|
|||||
|
2024
Q2 | $11.8M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $13.1M | Buy |
|
|||||
|
2023
Q3 | $21M | Sell |
|
|||||
|
2023
Q2 | $40.7M | Buy |
|
|||||
|
2023
Q1 | $27.9M | Hold |
|
|||||
|
2022
Q4 | $29.9M | Sell |
|
|||||
|
2022
Q3 | $42.7M | Sell |
|
|||||
|
2022
Q2 | $46M | Buy |
|
|||||
|
2022
Q1 | $29.2M | Buy |
|
|||||
|
2021
Q4 | $30.2M | Buy |
|